HDL and Glut1 inhibition reverse a hypermetabolic state in mouse models of myeloproliferative disorders.
about
Metabolic Flexibility and Dysfunction in Cardiovascular CellsCD36 deficiency impairs the small intestinal barrier and induces subclinical inflammation in mice.Testing the role of myeloid cell glucose flux in inflammation and atherosclerosisGlucose transport machinery reconstituted in cell models.The Warburg effect: evolving interpretations of an established conceptModeling cancer metabolism on a genome scale.Uncomplicating the Macrovascular Complications of Diabetes: The 2014 Edwin Bierman Award LectureA Novel Fluorescence Resonance Energy Transfer-Based Screen in High-Throughput Format To Identify Inhibitors of Malarial and Human Glucose TransportersDisruption of Glut1 in Hematopoietic Stem Cells Prevents Myelopoiesis and Enhanced Glucose Flux in Atheromatous Plaques of ApoE(-/-) Mice.Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cellsLoss of the co-repressor GPS2 sensitizes macrophage activation upon metabolic stress induced by obesity and type 2 diabetes.The greedy nature of mutant RAS: a boon for drug discovery targeting cancer metabolism?Increased Systemic and Plaque Inflammation in ABCA1 Mutation Carriers With Attenuation by Statins.Monocyte-Macrophages and T Cells in Atherosclerosis.Monocyte and macrophage immunometabolism in atherosclerosis.Upregulation of Glucose Uptake and Hexokinase Activity of Primary Human CD4+ T Cells in Response to Infection with HIV-1.Unexplained reciprocal regulation of diabetes and lipoproteins.
P2860
Q26796679-F9DED0D1-FA57-4D66-82D9-7C84C5AC97ACQ30834090-E1D03A06-1059-4F3A-B8AC-E855294A391FQ33612986-14F09DF7-BE37-4D9A-8344-CA8104048B32Q35019740-C9523D96-0C25-42D2-8640-9E22CE4067FDQ35169587-87C833BE-0AAA-4A74-9541-E87C34AEBD82Q35850350-A78D08B0-7B16-4B12-A90A-20A1709BEAF0Q35881759-B15952DC-6A5C-44AF-9BB2-0CAC3CF8758EQ36162383-09F83FFD-1323-462E-9C1A-6D801063532CQ36776429-C1C23F56-0C86-4E8C-812A-235B9C0796FAQ37615062-DE7BB460-E3C3-409F-9761-79CCF5DC8782Q38292180-5CCAAE0F-3F4D-4199-B265-19A5578D2935Q38612793-D023E8A4-F434-4A7D-B116-4DAA7F37BD3EQ40798941-0BF478B3-8E0F-4CA5-B967-DB9098321878Q47632654-9D09FB56-C9D6-4EDF-951F-0214B052FC3DQ48265798-5E9DA4F5-0B32-4871-80E2-F514951BDD26Q52727826-53D25994-4B46-4A2C-871D-2B89C8AE19ADQ53690107-430B2E82-7673-4013-9507-869566E6C697
P2860
HDL and Glut1 inhibition reverse a hypermetabolic state in mouse models of myeloproliferative disorders.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
HDL and Glut1 inhibition rever ...... myeloproliferative disorders.
@ast
HDL and Glut1 inhibition rever ...... myeloproliferative disorders.
@en
type
label
HDL and Glut1 inhibition rever ...... myeloproliferative disorders.
@ast
HDL and Glut1 inhibition rever ...... myeloproliferative disorders.
@en
prefLabel
HDL and Glut1 inhibition rever ...... myeloproliferative disorders.
@ast
HDL and Glut1 inhibition rever ...... myeloproliferative disorders.
@en
P2093
P2860
P50
P356
P1476
HDL and Glut1 inhibition rever ...... f myeloproliferative disorders
@en
P2093
Alan R Tall
Dieter Lütjohann
Gwendalyn J Randolph
Marit Westerterp
Neha Bhagwat
Ross L Levine
Serge Cremers
P2860
P304
P356
10.1084/JEM.20121357
P407
P577
2013-01-14T00:00:00Z